Metaverse meets microsurgery: XR platform aims to sharpen brain bypass precision

NCT ID NCT07711457

First seen Jul 17, 2026 · Last updated Jul 24, 2026 · Updated 2 times

Summary

This study tests a metaverse-based surgical platform that uses extended reality (XR) to help surgeons precisely locate blood vessels during brain bypass surgery. The trial includes 30 adults with moyamoya disease or chronic cerebral ischemia who need an extracranial-intracranial bypass. Before surgery, CT scans are loaded into the platform, and during the operation, XR overlays guide the surgeon to the donor and recipient arteries. The goal is to see if this technology improves localization accuracy and enables a less invasive approach.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
NTU OpVerse surgical simulation platform, a metaverse-based extended reality system for surgical planning and guidance
What this could lead to
If successful, this platform could make brain bypass surgery more precise and less invasive, potentially improving safety and recovery for patients with moyamoya disease or chronic cerebral ischemia.
What could go wrong
This is a small early-stage study with only 30 participants, so results may not apply broadly. The technology may not improve outcomes enough to justify its use in routine surgery.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AUGMENTED REALITY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • National Taiwan University Hospital

    RECRUITING

    Taipei, Taiwan

More trials for these conditions

Other studies related to the condition(s) this trial covers.